Posttranslational Modifications of Red Blood Cell Ghost Proteins as "Signatures" for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients.
作者信息
Pecankova Klara, Majek Pavel, Cermak Jaroslav, Dyr Jan E
机构信息
Institute of Hematology and Blood Transfusion, Prague, Czech Republic Phone: +420 221 977 349 E-mail:
出版信息
Turk J Haematol. 2017 Mar 1;34(1):111-113. doi: 10.4274/tjh.2016.0251. Epub 2016 Sep 9.
Abstract
摘要
相似文献
1
Posttranslational Modifications of Red Blood Cell Ghost Proteins as "Signatures" for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients.
Turk J Haematol. 2017 Mar 1;34(1):111-113. doi: 10.4274/tjh.2016.0251. Epub 2016 Sep 9.
2
Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes.骨髓增生异常综合征患者血浆蛋白羰基化增强。
Free Radic Biol Med. 2017 Jul;108:1-7. doi: 10.1016/j.freeradbiomed.2017.03.007. Epub 2017 Mar 12.
3
Hsp70 Trap Assay for Detection of Misfolded Subproteome Related to Myelodysplastic Syndromes.Hsp70 陷阱测定法检测与骨髓增生异常综合征相关的错误折叠亚蛋白组。
Anal Chem. 2019 Nov 19;91(22):14226-14230. doi: 10.1021/acs.analchem.9b04175. Epub 2019 Oct 29.
4
Ferrokinetic abnormalities and red cell life span in myelodysplastic syndromes: a review.
Scand J Haematol Suppl. 1986;45:48-52. doi: 10.1111/j.1600-0609.1986.tb00842.x.
5
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study.低危骨髓增生异常综合征患者红细胞糖酵解活性及丙酮酸激酶激活剂 AG-946 的体外作用：一项概念验证研究。
Am J Hematol. 2024 Jun;99(6):1201-1204. doi: 10.1002/ajh.27300. Epub 2024 Apr 2.
6
Abnormalities of cytoskeletal proteins of the red blood cells in myelodysplastic syndromes.骨髓增生异常综合征中红细胞细胞骨架蛋白的异常
Int J Hematol. 1994 Apr;59(3):227-9.
7
Abnormal mitosis and multiple micronucleation in myelodysplastic syndrome: a presage to a red cell tragedy?
Blood. 2016 Nov 10;128(19):2371. doi: 10.1182/blood-2016-08-729913.
8
A case of myelodysplastic syndrome presenting with faggot-like cells.
Int J Hematol. 2013 Apr;97(4):443-5. doi: 10.1007/s12185-013-1306-z. Epub 2013 Mar 9.
9
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.红细胞同种免疫与骨髓增生异常综合征自身抗体的产生和红细胞输注需求增加有关。
Haematologica. 2017 Dec;102(12):2021-2029. doi: 10.3324/haematol.2017.175752. Epub 2017 Oct 5.
10
PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes.
Leukemia. 2008 Jan;22(1):198-200. doi: 10.1038/sj.leu.2404855. Epub 2007 Jul 12.
本文引用的文献
1
Biomarkers of oxidative stress in red blood cells.红细胞氧化应激的生物标志物。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Jun;155(2):131-6. doi: 10.5507/bp.2011.027.
2
Sweet silver: a formaldehyde-free silver staining using aldoses as developing agents, with enhanced compatibility with mass spectrometry.甜蜜银染法：一种以醛糖为显影剂的无甲醛银染法，与质谱分析的兼容性增强。
Proteomics. 2008 Dec;8(23-24):4853-61. doi: 10.1002/pmic.200800321.
3
Red cell morphology in leukemia, hypoplastic anemia and myelodysplastic syndrome.白血病、再生障碍性贫血和骨髓增生异常综合征中的红细胞形态。
Pathophysiology. 2006 Dec;13(4):217-25. doi: 10.1016/j.pathophys.2006.06.002. Epub 2006 Jul 28.
4
The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.人红细胞无血红蛋白空泡的制备及其化学特性
Arch Biochem Biophys. 1963 Jan;100:119-30. doi: 10.1016/0003-9861(63)90042-0.
5
Abnormal erythrocyte band 4.1 protein in myelodysplastic syndrome with elliptocytosis.
Br J Haematol. 1993 Oct;85(2):387-92. doi: 10.1111/j.1365-2141.1993.tb03183.x.
6
Modulation of erythrocyte membrane mechanical function by beta-spectrin phosphorylation and dephosphorylation.β-血影蛋白磷酸化和去磷酸化对红细胞膜机械功能的调节
J Biol Chem. 1995 Mar 10;270(10):5659-65. doi: 10.1074/jbc.270.10.5659.
Zotero 插件